Unlike normal chemotherapy treatments that are given through an IV and circulated through the bloodstream, this treatment is performed at the time of surgery for cancer and the chemotherapy is heated ...

Liver cancer treatment has advanced from intravenous delivery of chemotherapy drugs, which affects not only the tumor and liver but also organs throughout the body (red, left), to intra-arterial ...

Enriqueta Felip, MD, PhD, discusses the design of the phase 3 3475A-D77 trial evaluating subcutaneous pembrolizumab in metastatic NSCLC.

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...

Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer.

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy and safety profile with IV pembrolizumab.

Intravenous infusion pumps ensure controlled, regulated, & error-free delivery of nutrients and medications while treating patients via radiation therapy or chemotherapy, as these are very complex ...